Jotin Marango - 25 Apr 2022 Form 3 Insider Report for Ikena Oncology, Inc. (IKNA)

Role: CFO & Head of Corp. Dev.
Signature: /s/ Jotin Marango
Issuer symbol: IKNA
Transactions as of: 25 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 25 Apr 2022, 18:48:47 UTC
Previous filing: 20 Jan 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney